Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | S9562 |
| Short Description | Ht inj palivizumab/ab diem |
| Long Description | Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
| Pricing indicator | 00 |
| Coverage code | I |
| ASC payment group code | |
| BETOS2 code | Z2 |
| Action code | N |
| Type of service | 9 |
| Effective date | 2023-04-01 |
| Date Added | 2003-01-01 |
Drug Details
-
Palivizumab injection is used to help prevent respiratory syncytial virus (RSV; common virus that can cause serious lung infections) in children less than 24 months old who are at high risk for getting RSV. Children at high risk for RSV include those who were born prematurely or have certain heart or lung diseases. Palivizumab injection is not used to treat the symptoms of RSV disease once a child already has it. Palivizumab injection is in a class of medications called monoclonal antibodies. It works by helping the immune system to slow or stop the spread of the virus in the body.